| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Metformin | FAERS: 5 | US FAERS | |
| 2 | Cetirizine | FAERS: 3 | US FAERS | |
| 3 | Amoxicillin-Potassium Clavulanate Combination | FAERS: 2 | US FAERS | |
| 4 | Guaifenesin | FAERS: 2 | US FAERS | |
| 5 | Capecitabine | FAERS: 1 | US FAERS | |
| 6 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 7 | Cetirizine | FAERS: 1 | US FAERS | |
| 8 | Colesevelam Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 11 | Qlaira | FAERS: 1 | US FAERS | |
| 12 | aliskiren | FAERS: 1 | US FAERS | |
| 13 | pasireotide | FAERS: 1 | US FAERS | |
| 14 | Atazanavir Sulfate | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.